Patent on hyperactivity drug taken away by court
Patent on hyperactivity drug taken away by court
Eli Lilly & Co of Indianapolis in the US has had to revise revenue outlook after losing its patent lawsuit over the attention deficit hyperactivity drug, Strattera.